- call +1-201-465-4211
- email sales@mrinsights.biz
The major factors driving this market are the increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination.
Scope of the Report:
This report focuses on the Mycoplasma Testing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The Asia region is estimated to grow at the fastest rate which can be attributed to the increasing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.
The worldwide market for Mycoplasma Testing is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Charles River Laboratories International
Merck Kgaa
Lonza Group
Roche Diagnostics
SGS
Thermo Fisher Scientific
American Type Culture Collection
Biounique Testing Laboratories
Invivogen
Promocell
Biological Industries Israel Beit Haemek
Wuxi Apptec
Norgen Biotek
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
PCR
ELSA
Enzymatic Methods
DNA Staining
Market Segment by Applications, can be divided into
Cell Line Testing
Virus Testing
There are 15 Chapters to deeply display the global Mycoplasma Testing market.
Chapter 1, to describe Mycoplasma Testing Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Mycoplasma Testing, with sales, revenue, and price of Mycoplasma Testing, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Mycoplasma Testing, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Mycoplasma Testing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Mycoplasma Testing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Mycoplasma Testing Introduction
1.2 Market Analysis by Type
1.2.1 PCR
1.2.2 ELSA
1.2.3 Enzymatic Methods
1.2.4 DNA Staining
1.3 Market Analysis by Applications
1.3.1 Cell Line Testing
1.3.2 Virus Testing
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Charles River Laboratories International
2.1.1 Business Overview
2.1.2 Mycoplasma Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Charles River Laboratories International Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck Kgaa
2.2.1 Business Overview
2.2.2 Mycoplasma Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Kgaa Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Lonza Group
2.3.1 Business Overview
2.3.2 Mycoplasma Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Lonza Group Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Roche Diagnostics
2.4.1 Business Overview
2.4.2 Mycoplasma Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Diagnostics Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 SGS
2.5.1 Business Overview
2.5.2 Mycoplasma Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 SGS Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Thermo Fisher Scientific
2.6.1 Business Overview
2.6.2 Mycoplasma Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Thermo Fisher Scientific Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 American Type Culture Collection
2.7.1 Business Overview
2.7.2 Mycoplasma Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 American Type Culture Collection Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biounique Testing Laboratories
2.8.1 Business Overview
2.8.2 Mycoplasma Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biounique Testing Laboratories Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Invivogen
2.9.1 Business Overview
2.9.2 Mycoplasma Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Invivogen Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Promocell
2.10.1 Business Overview
2.10.2 Mycoplasma Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Promocell Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Biological Industries Israel Beit Haemek
2.11.1 Business Overview
2.11.2 Mycoplasma Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biological Industries Israel Beit Haemek Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Wuxi Apptec
2.12.1 Business Overview
2.12.2 Mycoplasma Testing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Wuxi Apptec Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Norgen Biotek
2.13.1 Business Overview
2.13.2 Mycoplasma Testing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Norgen Biotek Mycoplasma Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Mycoplasma Testing Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Mycoplasma Testing Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Mycoplasma Testing Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Mycoplasma Testing Manufacturer Market Share in 2017
3.3.2 Top 6 Mycoplasma Testing Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Mycoplasma Testing Market Analysis by Regions
4.1 Global Mycoplasma Testing Sales, Revenue and Market Share by Regions
4.1.1 Global Mycoplasma Testing Sales and Market Share by Regions (2013-2018)
4.1.2 Global Mycoplasma Testing Revenue and Market Share by Regions (2013-2018)
4.2 North America Mycoplasma Testing Sales and Growth Rate (2013-2018)
4.3 Europe Mycoplasma Testing Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Mycoplasma Testing Sales and Growth Rate (2013-2018)
4.5 South America Mycoplasma Testing Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Mycoplasma Testing Sales and Growth Rate (2013-2018)
5 North America Mycoplasma Testing by Countries
5.1 North America Mycoplasma Testing Sales, Revenue and Market Share by Countries
5.1.1 North America Mycoplasma Testing Sales and Market Share by Countries (2013-2018)
5.1.2 North America Mycoplasma Testing Revenue and Market Share by Countries (2013-2018)
5.2 United States Mycoplasma Testing Sales and Growth Rate (2013-2018)
5.3 Canada Mycoplasma Testing Sales and Growth Rate (2013-2018)
5.4 Mexico Mycoplasma Testing Sales and Growth Rate (2013-2018)
6 Europe Mycoplasma Testing by Countries
6.1 Europe Mycoplasma Testing Sales, Revenue and Market Share by Countries
6.1.1 Europe Mycoplasma Testing Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Mycoplasma Testing Revenue and Market Share by Countries (2013-2018)
6.2 Germany Mycoplasma Testing Sales and Growth Rate (2013-2018)
6.3 UK Mycoplasma Testing Sales and Growth Rate (2013-2018)
6.4 France Mycoplasma Testing Sales and Growth Rate (2013-2018)
6.5 Russia Mycoplasma Testing Sales and Growth Rate (2013-2018)
6.6 Italy Mycoplasma Testing Sales and Growth Rate (2013-2018)
7 Asia-Pacific Mycoplasma Testing by Countries
7.1 Asia-Pacific Mycoplasma Testing Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Mycoplasma Testing Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Mycoplasma Testing Revenue and Market Share by Countries (2013-2018)
7.2 China Mycoplasma Testing Sales and Growth Rate (2013-2018)
7.3 Japan Mycoplasma Testing Sales and Growth Rate (2013-2018)
7.4 Korea Mycoplasma Testing Sales and Growth Rate (2013-2018)
7.5 India Mycoplasma Testing Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Mycoplasma Testing Sales and Growth Rate (2013-2018)
8 South America Mycoplasma Testing by Countries
8.1 South America Mycoplasma Testing Sales, Revenue and Market Share by Countries
8.1.1 South America Mycoplasma Testing Sales and Market Share by Countries (2013-2018)
8.1.2 South America Mycoplasma Testing Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Mycoplasma Testing Sales and Growth Rate (2013-2018)
8.3 Argentina Mycoplasma Testing Sales and Growth Rate (2013-2018)
8.4 Colombia Mycoplasma Testing Sales and Growth Rate (2013-2018)
9 Middle East and Africa Mycoplasma Testing by Countries
9.1 Middle East and Africa Mycoplasma Testing Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Mycoplasma Testing Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Mycoplasma Testing Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Mycoplasma Testing Sales and Growth Rate (2013-2018)
9.3 UAE Mycoplasma Testing Sales and Growth Rate (2013-2018)
9.4 Egypt Mycoplasma Testing Sales and Growth Rate (2013-2018)
9.5 Nigeria Mycoplasma Testing Sales and Growth Rate (2013-2018)
9.6 South Africa Mycoplasma Testing Sales and Growth Rate (2013-2018)
10 Global Mycoplasma Testing Market Segment by Type
10.1 Global Mycoplasma Testing Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Mycoplasma Testing Sales and Market Share by Type (2013-2018)
10.1.2 Global Mycoplasma Testing Revenue and Market Share by Type (2013-2018)
10.2 PCR Sales Growth and Price
10.2.1 Global PCR Sales Growth (2013-2018)
10.2.2 Global PCR Price (2013-2018)
10.3 ELSA Sales Growth and Price
10.3.1 Global ELSA Sales Growth (2013-2018)
10.3.2 Global ELSA Price (2013-2018)
10.4 Enzymatic Methods Sales Growth and Price
10.4.1 Global Enzymatic Methods Sales Growth (2013-2018)
10.4.2 Global Enzymatic Methods Price (2013-2018)
10.5 DNA Staining Sales Growth and Price
10.5.1 Global DNA Staining Sales Growth (2013-2018)
10.5.2 Global DNA Staining Price (2013-2018)
11 Global Mycoplasma Testing Market Segment by Application
11.1 Global Mycoplasma Testing Sales Market Share by Application (2013-2018)
11.2 Cell Line Testing Sales Growth (2013-2018)
11.3 Virus Testing Sales Growth (2013-2018)
12 Mycoplasma Testing Market Forecast (2018-2023)
12.1 Global Mycoplasma Testing Sales, Revenue and Growth Rate (2018-2023)
12.2 Mycoplasma Testing Market Forecast by Regions (2018-2023)
12.2.1 North America Mycoplasma Testing Market Forecast (2018-2023)
12.2.2 Europe Mycoplasma Testing Market Forecast (2018-2023)
12.2.3 Asia-Pacific Mycoplasma Testing Market Forecast (2018-2023)
12.2.4 South America Mycoplasma Testing Market Forecast (2018-2023)
12.2.5 Middle East and Africa Mycoplasma Testing Market Forecast (2018-2023)
12.3 Mycoplasma Testing Market Forecast by Type (2018-2023)
12.3.1 Global Mycoplasma Testing Sales Forecast by Type (2018-2023)
12.3.2 Global Mycoplasma Testing Market Share Forecast by Type (2018-2023)
12.4 Mycoplasma Testing Market Forecast by Application (2018-2023)
12.4.1 Global Mycoplasma Testing Sales Forecast by Application (2018-2023)
12.4.2 Global Mycoplasma Testing Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Mycoplasma Testing Picture
Table Product Specifications of Mycoplasma Testing
Figure Global Sales Market Share of Mycoplasma Testing by Types in 2017
Ta
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
